Could warning labels reduce soda consumption? Read the week’s top stories in endocrinology
A study presented at ObesityWeek showed that people were more likely to consider the negative health effects of drinking soda if the beverages came with warning labels on the packaging. This was the week’s top story in endocrinology.
Another popular story discussed findings published in Morbidity and Mortality Weekly Report, which showed that the incidence of diabetes may be declining among older adults in the United States.
Including warning labels may limit soda consumption
Consumers report more consistently considering the negative health effects of drinking soda and other sugary beverages when health warning labels are included in packaging, according to findings presented at ObesityWeek. Read more.
Diabetes incidence decreases, prevalence plateaus among Medicare beneficiaries
The prevalence of diabetes among adults aged at least 68 years has plateaued in recent years, and an analysis of Medicare claims data suggests diabetes incidence also has declined, according to findings published in Morbidity and Mortality Weekly Report. Read more.
Intermittent fasting research still developing, time-restricted feeding shows potential
Among the numerous intermittent fasting strategies being pursued for weight loss, time-restricted feeding has shown particular promise, according to a speaker at ObesityWeek. Read more.
Experts warn PFAS endocrine-disrupting chemicals may drive obesity, osteoporosis
A class of endocrine-disrupting chemicals known as PFAS may work as an “environmental trigger” to drive multiple adverse endocrine health effects, including obesity, thyroid dysfunction and low bone mineral density, although researchers caution that more studies on potential associations are needed. Read more.
Age, hypothyroidism type influence all-cause mortality risk in older adults
All-cause mortality risk is greater for adults aged at least 60 years with overt hypothyroidism compared with adults with euthyroidism, but the same is not true for cardiovascular mortality risk, according to findings presented at the annual meeting of the American Thyroid Association. Read more.